REQUEST A DEMO
Total
USD $0.00
Search more companies

Comex Mgmedical S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Comex Mgmedical S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English & Spanish Download a sample report

Comex Mgmedical S.A. is an enterprise in Ecuador, with the main office in Quito. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on August 25, 2015. It currently has a total number of 4 (2020) employees. The latest financial highlights indicate a net sales revenue increase of 580.74% in 2020. Its’ total assets recorded a growth of 8.4%.

Headquarters
de los Guayacanes Casa 22
Quito; Pichincha;

Contact Details: Purchase the Comex Mgmedical S.A. report to view the information.

Website: http://www.comexmgmedical.com

Basic Information
Total Employees:
Purchase the Comex Mgmedical S.A. report to view the information.
Outstanding Shares:
Purchase the Comex Mgmedical S.A. report to view the information.
Registered Capital:
Purchase the Comex Mgmedical S.A. report to view the information.
Incorporation Date:
August 25, 2015
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
75%
Purchase this report to view the information.
25%
Company Performance
Financial values in the chart are available after Comex Mgmedical S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
580.74%
Total operating revenue
580.74%
Operating profit (EBIT)
580.71%
Net Profit (Loss) for the Period
580.57%
Total assets
8.4%
Total equity
1.03%
Operating Profit Margin (ROS)
0%
Net Profit Margin
0%
Return on Equity (ROE)
1.01%
Debt to Equity Ratio
9.29%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?